etanidazole and tirapazamine

etanidazole has been researched along with tirapazamine in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (62.50)	18.2507
2000's	1 (12.50)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chopra, S; Doppalapudi, RS; Franzblau, SG; Green, CE; Iyer, LV; Koolpe, GA; Madrid, PB; Matsuyama, KN; Riccio, ES; Ryan, KJ; Tambo-Ong, AA; Tran, TB; Wan, B	1
Goris, ML; Knox, SJ; McGann, JK; Minchinton, AI; Sutherland, WR; Waller, EK; Wilder, RB	1
Giuliano, J; Lee, DJ; Moini, M; Westra, WH	1
Brown, JM; Dorie, MJ; Menke, DR; Siim, BG	1
Lehnert, S; Lloyd, DK; Yapp, DT; Zhu, J	1
Fahlman, C; Tabassi, K; Williams, JA; Yuan, X	1
Le, QT	1
Foehrenbacher, A; Hay, MP; Hicks, KO; Patel, R; Su, J; Wang, J; Wilson, WR	1

Reviews

1 review(s) available for etanidazole and tirapazamine

Article	Year
Hypoxic sensitizer and cytotoxin for head and neck cancer. Annals of the Academy of Medicine, Singapore, 1996, Volume: 25, Issue:3 Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Hypoxia; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Etanidazole; Head and Neck Neoplasms; Humans; Hyperbaric Oxygenation; Mice; Microelectrodes; Misonidazole; Oxygen Consumption; Radiation Tolerance; Radiation-Sensitizing Agents; Survival Rate; Tirapazamine; Treatment Outcome; Triazines	1996

Article

Year

Hypoxic sensitizer and cytotoxin for head and neck cancer.

Annals of the Academy of Medicine, Singapore, 1996, Volume: 25, Issue:3

Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Hypoxia; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Etanidazole; Head and Neck Neoplasms; Humans; Hyperbaric Oxygenation; Mice; Microelectrodes; Misonidazole; Oxygen Consumption; Radiation Tolerance; Radiation-Sensitizing Agents; Survival Rate; Tirapazamine; Treatment Outcome; Triazines

1996

Other Studies

7 other study(ies) available for etanidazole and tirapazamine

Article	Year
Discovery and optimization of benzotriazine di-N-oxides targeting replicating and nonreplicating Mycobacterium tuberculosis. Journal of medicinal chemistry, 2012, Jul-12, Volume: 55, Issue:13 Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Discovery; Female; Isomerism; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrofurans; Nitroimidazoles; Oxides; Quinoxalines; Rats; Tirapazamine; Triazines; Tuberculosis; Vero Cells	2012
The hypoxic cytotoxin SR 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenografts. International journal of radiation oncology, biology, physics, 1994, Jan-01, Volume: 28, Issue:1 Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Etanidazole; Humans; Lymphoma, Non-Hodgkin; Mice; Mice, SCID; Radiation-Sensitizing Agents; Radioimmunotherapy; Tirapazamine; Transplantation, Heterologous; Triazines	1994
Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia. Cancer research, 1997, Jul-15, Volume: 57, Issue:14 Topics: Animals; Antineoplastic Agents; Cell Hypoxia; DNA; DNA Damage; Etanidazole; Humans; Hydrocarbons, Fluorinated; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Radiation-Sensitizing Agents; Tirapazamine; Triazines	1997
Radiosensitization of a mouse tumor model by sustained intra-tumoral release of etanidazole and tirapazamine using a biodegradable polymer implant device. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1999, Volume: 53, Issue:1 Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Drug Implants; Etanidazole; Female; Fibrosarcoma; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Polymers; Radiation-Sensitizing Agents; Radiotherapy Dosage; Tirapazamine; Triazines	1999
Synthetic, implantable, biodegradable polymers for controlled release of radiosensitizers. Cancer biotherapy & radiopharmaceuticals, 1999, Volume: 14, Issue:3 Topics: Biocompatible Materials; Biodegradation, Environmental; Decanoic Acids; Delayed-Action Preparations; Drug Implants; Etanidazole; Humans; Idoxuridine; Kinetics; Polyesters; Radiation-Sensitizing Agents; Tirapazamine; Triazines	1999
Identifying and targeting hypoxia in head and neck cancer: a brief overview of current approaches. International journal of radiation oncology, biology, physics, 2007, Volume: 69, Issue:2 Suppl Topics: Antigens, Neoplasm; Biomarkers; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Squamous Cell; Cell Hypoxia; Electrodes; Etanidazole; Head and Neck Neoplasms; Humans; Hydrocarbons, Fluorinated; Intracellular Signaling Peptides and Proteins; Mitochondrial Proteins; Neoplasm Proteins; Nitroimidazoles; Osteopontin; Oxygen; Partial Pressure; Radiation-Sensitizing Agents; Tirapazamine; Triazines	2007
The 2-nitroimidazole EF5 is a biomarker for oxidoreductases that activate the bioreductive prodrug CEN-209 under hypoxia. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Mar-15, Volume: 18, Issue:6 Topics: Animals; Calcium-Binding Proteins; Cell Cycle Proteins; Cell Hypoxia; Cell Line, Tumor; Cyclic N-Oxides; Etanidazole; Female; HCT116 Cells; Histones; Humans; Hydrocarbons, Fluorinated; Indicators and Reagents; Mice; Oxidoreductases; Prodrugs; Tirapazamine; Transplantation, Heterologous; Triazines	2012